FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D)

PMA: P010012 · Supplement: S542 · Decision Sep 24, 2021
Classifications
1
FEI Numbers
26
Registration Numbers
26

Basic Information

Device Name
Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D)
Trade Name
CONTAK CD, CONTAK RENEWAL, LIVIAN, COGNIS, ENERGEN CRT-D, PUNCTUA CRT-D, INCEPTA CRT-D, ORIGEN CRT-D, INOGEN CRT-D, DYNA
PMA Number
P010012
Supplement Number
S542
Device Class
FDA Class 3
Product Code
NIK
Generic Name
Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D)
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
September 24, 2021
Date Received
September 1, 2021
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

Use a new controlled environment area at the Boston Scientific Dorado, Puerto Rico facility.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NIK Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D)